Upgrade to SI Premium - Free Trial

FDA accepts Genentech's application for Lunsumio and Polivy combo

June 18, 2026 1:00 AM
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA